Dysfluency secondary to CNS damage - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Dysfluency secondary to CNS damage

Description:

True neurogenic stuttering is also known as 'acquired' ... Disfluency stemming from anomia. Palilalia. Dysarthric disfluency ... Dysfluency stemming from anomia ... – PowerPoint PPT presentation

Number of Views:240
Avg rating:3.0/5.0
Slides: 15
Provided by: nrat
Category:

less

Transcript and Presenter's Notes

Title: Dysfluency secondary to CNS damage


1
Dysfluency secondary to CNS damage
2
Subgroups of acquired fluency disorders
  • True neurogenic stuttering is also known as
    acquired or cortical stuttering.
  • However, it must be distinguished from other
    fluency disturbances following CNS damage that
    share few features with classic stuttering
  • Subgroups include
  • Dysarthric disfluency
  • Apraxic disfluency
  • Disfluency stemming from anomia
  • Palilalia

3
Dysarthric disfluency
  • This category includes Parkinsonian patients, who
    often demonstrate
  • Frequent prolongations
  • Rapid sound, syllable and word repetitions
  • blocking associated with failure to progress to
    the next articulatory target
  • Symptoms worsen as the disease progresses (Benke,
    et al., 2000) levodopa treatment may further
    aggravate fluency (Louis, et al., 2001)

4
Dysarthria (continued)
  • PD may prompt re-emergence of developmental
    stuttering (Shahed Jonkovic, 2001).
  • Ataxic dysarthrics may show
  • Long prolongations
  • Easy repetitions

5
Other subgroups
  • Apraxic dysfluency apraxic patients often repeat
    initial segments while groping for the
    appropriate target this needs to be
    distinguished from the stuttering behavior of
    perseverative repetitions of the correct target,
    as in true stuttering. Both may be seen in
    apraxia.
  • Some people have suggested that the two disorders
    share a common neurological basis.

6
Dysfluency stemming from anomia
  • Dysfluencies are characterized primarily by
    pausing, articulatory groping, and the
    interjection of filled pauses and/or phrase
    repetitions while searching for lexical targets.
  • Usually, other additional aphasic symptoms are
    present
  • Wernickes patients may be more prone to this
    pattern of dysfluency than other aphasic
    syndromes.

7
Palilalia
  • Found in a number of neurological conditions
    (including Parkinsons), speech is characterized
    primarily by
  • word and phrase repetitions (NOT) sound or
    syllable repetitions) that may become
    increasingly more rapid, and progressively more
    unintelligible.

8
True cortical stuttering
  • Quite rare
  • Typically documented in the literature through
    isolated case studies
  • Patients show true stutter-like symptoms which
    cannot be attributed to neuromotor or language
    planning disturbance

9
Causes of cortical stuttering
  • Stroke, typically multiple and bilateral events
  • However, site of lesion has been reported to be
    extremely variable (Franco, et al., 2000
    including subcortical regions Ciabarra, et al.,
    2000) and occasionally subtle enough to be
    detected only using very sophisticated measures
    (e.g., SPECT, Heuer, et al., 1996).
  • This variability has impeded the use of acquired
    stuttering cases to shed light on the underlying
    defect in developmental stuttering.
  • Stroke sometimes prompts return of resolved
    developmental stuttering (Mouradian, et al., 2000)

10
Causes (continued)
  • Penetrating objects and tumors
  • Occasionally, there are reports of stuttering
    caused/cured by removal of tumors or invasive
    objects
  • CHI these cases typically show
  • bilateral involvement
  • loss of consciousness after injury
  • Development of seizure disorder
  • Emergence of stuttering following establishment
    of seizure disorder
  • Senile and dialysis dementia

11
Drug-induced stuttering
  • A wide number of medications have been reported
    to induce disfluency, including some that have
    been shown to marginally increase fluency in
    developmental stuttering (Brady, 1998).
  • Similarly, while trials continue to explore the
    use of medication in alleviating stuttering
    (e.g., resperidone, Maguire, et al., 2000)),
    there is some consensus that medications will
    best augment, rather than replace, conventional
    therapy in stuttering treatment.

12
Overlap Neurogenic and psychogenic stuttering
  • Psychogenic stuttering, while rare, typically
    shows some symptom overlap with neurogenic
    dysfluency
  • Patients often show evidence of some degree of
    neurological insult or disease state
  • Differential diagnosis is important, and focuses
    on ruling out potential alternative explanations
    for the dysfluency, while gauging pt. profile
    similarity to known neurogenic subgroups (see
    Helm-Estabrooks Hotz (1998) for case study
    example.)

13
Features of neurogenic and psychogenic
stuttering (from Manning, 2001)
  • NEUROGENIC
  • Disfluencies on function as well as content words
  • Speaker annoyed but not usually anxious
  • Behaviors not solely on initial syllables
  • Secondary symptoms not linked to disfluencies
  • Lack of adaptation effect
  • lack of variability across speaking tasks and
    situations
  • PSYCHOGENIC
  • Rapid and favorable response to limited treatment
  • Bizarre struggle and other signs of anxiety
  • Stuttering may be episodic
  • Stuttering pattern differs from both
    developmental and neurogenic stuttering

14
Treatment
  • If stuttering is accompanied by seizure disorder,
    medications to control seizures often ameliorate
    dysfluency
  • Remission most often occurs within three months
    persistent cases have less favorable prognosis
  • Combination of fluency shaping (emphasis on rate
    and pacing) and stuttering modification (to
    reduce struggle) is most often recommended.
    Limited efficacy data are available.
Write a Comment
User Comments (0)
About PowerShow.com